SG192793A1 - Synthesis of 2-carboxamide cycloamino urea derivatives - Google Patents

Synthesis of 2-carboxamide cycloamino urea derivatives Download PDF

Info

Publication number
SG192793A1
SG192793A1 SG2013062153A SG2013062153A SG192793A1 SG 192793 A1 SG192793 A1 SG 192793A1 SG 2013062153 A SG2013062153 A SG 2013062153A SG 2013062153 A SG2013062153 A SG 2013062153A SG 192793 A1 SG192793 A1 SG 192793A1
Authority
SG
Singapore
Prior art keywords
formula
compound
solvent
contacting
solvents
Prior art date
Application number
SG2013062153A
Other languages
English (en)
Inventor
Bernhard Erb
Isabelle Sylvie Gallou
Florian Karl Kleinbeck
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=45787206&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SG192793(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of SG192793A1 publication Critical patent/SG192793A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/26Radicals substituted by halogen atoms or nitro radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/06Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom
    • C07D213/16Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom containing only one pyridine ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
SG2013062153A 2011-03-03 2012-03-01 Synthesis of 2-carboxamide cycloamino urea derivatives SG192793A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161448774P 2011-03-03 2011-03-03
PCT/EP2012/053559 WO2012117071A1 (en) 2011-03-03 2012-03-01 Synthesis of 2-carboxamide cycloamino urea derivatives

Publications (1)

Publication Number Publication Date
SG192793A1 true SG192793A1 (en) 2013-09-30

Family

ID=45787206

Family Applications (1)

Application Number Title Priority Date Filing Date
SG2013062153A SG192793A1 (en) 2011-03-03 2012-03-01 Synthesis of 2-carboxamide cycloamino urea derivatives

Country Status (33)

Country Link
US (3) US9650373B2 (enExample)
EP (1) EP2681192B1 (enExample)
JP (1) JP6022485B2 (enExample)
KR (1) KR101851421B1 (enExample)
CN (2) CN103402982B (enExample)
AR (2) AR088714A1 (enExample)
AU (1) AU2012222346B2 (enExample)
BR (1) BR112013021882A2 (enExample)
CA (1) CA2828509C (enExample)
CL (1) CL2013002521A1 (enExample)
CO (1) CO6751286A2 (enExample)
DK (1) DK2681192T3 (enExample)
EA (4) EA032802B1 (enExample)
EC (1) ECSP13012914A (enExample)
ES (1) ES2663717T3 (enExample)
GT (1) GT201300211A (enExample)
HU (1) HUE036319T2 (enExample)
IL (1) IL228023A (enExample)
MA (1) MA34982B1 (enExample)
MX (2) MX351740B (enExample)
MY (1) MY163214A (enExample)
NO (1) NO2681192T3 (enExample)
PE (1) PE20140917A1 (enExample)
PH (1) PH12013501796A1 (enExample)
PL (1) PL2681192T3 (enExample)
PT (1) PT2681192T (enExample)
SG (1) SG192793A1 (enExample)
SI (1) SI2681192T1 (enExample)
TN (1) TN2013000354A1 (enExample)
TW (2) TWI607994B (enExample)
UA (1) UA112539C2 (enExample)
WO (1) WO2012117071A1 (enExample)
ZA (1) ZA201306174B (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA112539C2 (uk) * 2011-03-03 2016-09-26 Новартіс Аг Спосіб одержання похідних 2-карбоксамідциклоаміносечовини
CN107108442A (zh) * 2014-11-14 2017-08-29 燿石治疗公司 用于制备α,ω‑二羧酸封端的二烷醚的方法和中间体
CN112961090A (zh) * 2019-12-13 2021-06-15 武汉九州钰民医药科技有限公司 合成Alpelisib的关键中间体及其制备方法
CN110964005A (zh) * 2019-12-16 2020-04-07 武汉九州钰民医药科技有限公司 一种Alpelisib的制备工艺
CN111057051A (zh) * 2019-12-16 2020-04-24 武汉九州钰民医药科技有限公司 PI3K抑制剂Alpelisib的新合成方法
KR20220125753A (ko) 2021-03-05 2022-09-14 배성륭 기능성 풍력 발전시스템
CN119462487A (zh) * 2023-08-08 2025-02-18 重庆博腾制药科技股份有限公司 一种阿培利司中间体4-甲基吡啶类化合物的制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3534056A (en) * 1967-03-02 1970-10-13 Pennwalt Corp Fluoro-alkyl pyridines and their preparation
UA60365C2 (uk) 1998-06-04 2003-10-15 Пфайзер Продактс Інк. Похідні ізотіазолу, спосіб їх одержання, фармацевтична композиція та спосіб лікування гіперпроліферативного захворювання у ссавця
CA2384101A1 (en) 1999-09-10 2001-03-15 Merck & Co., Inc. Tyrosine kinase inhibitors
TW200519106A (en) * 2003-05-02 2005-06-16 Novartis Ag Organic compounds
EP1983980A4 (en) * 2006-01-25 2010-05-05 Synta Pharmaceuticals Corp THIAZOL AND THIADIAZOL COMPOUNDS FOR USES IN RELATION TO INFLAMMATION AND IMMUNITY
TWI428091B (zh) 2007-10-23 2014-03-01 Du Pont 殺真菌劑混合物
WO2009080694A1 (en) 2007-12-20 2009-07-02 Novartis Ag Thiazole derivatives used as pi 3 kinase inhibitors
WO2009080649A2 (en) * 2007-12-21 2009-07-02 Telefonaktiebolaget Lm Ericsson (Publ) Improvements in or relating to wireless mobility
UA104147C2 (uk) * 2008-09-10 2014-01-10 Новартис Аг Похідна піролідиндикарбонової кислоти та її застосування у лікуванні проліферативних захворювань
UA112539C2 (uk) * 2011-03-03 2016-09-26 Новартіс Аг Спосіб одержання похідних 2-карбоксамідциклоаміносечовини

Also Published As

Publication number Publication date
CN103402982B (zh) 2016-07-13
MA34982B1 (fr) 2014-03-01
EA201792068A2 (ru) 2018-01-31
KR20140009432A (ko) 2014-01-22
TW201247660A (en) 2012-12-01
MX2013010132A (es) 2013-10-30
UA112539C2 (uk) 2016-09-26
AR088714A1 (es) 2014-07-02
EP2681192B1 (en) 2017-12-27
PL2681192T3 (pl) 2018-06-29
ZA201306174B (en) 2014-05-28
CL2013002521A1 (es) 2014-02-14
MX347348B (es) 2017-04-17
PH12013501796A1 (en) 2022-10-26
EA201792068A3 (ru) 2018-05-31
JP2014511387A (ja) 2014-05-15
EP2681192A1 (en) 2014-01-08
WO2012117071A1 (en) 2012-09-07
DK2681192T3 (en) 2018-04-16
EA032802B1 (ru) 2019-07-31
BR112013021882A2 (pt) 2016-07-19
TWI597279B (zh) 2017-09-01
EA201691331A1 (ru) 2017-01-30
MX351740B (es) 2017-10-26
TW201722916A (zh) 2017-07-01
AR123584A2 (es) 2022-12-21
MY163214A (en) 2017-08-30
JP6022485B2 (ja) 2016-11-09
EA201391267A1 (ru) 2014-01-30
CN106083840A (zh) 2016-11-09
PT2681192T (pt) 2018-04-02
TWI607994B (zh) 2017-12-11
ECSP13012914A (es) 2013-11-29
US20170355677A1 (en) 2017-12-14
NZ614173A (en) 2015-04-24
PE20140917A1 (es) 2014-08-14
EA025381B1 (ru) 2016-12-30
GT201300211A (es) 2014-12-30
US10059670B2 (en) 2018-08-28
SI2681192T1 (en) 2018-04-30
US20170240509A1 (en) 2017-08-24
CO6751286A2 (es) 2013-09-16
KR101851421B1 (ko) 2018-04-23
CA2828509C (en) 2018-11-20
US9650373B2 (en) 2017-05-16
AU2012222346A1 (en) 2013-08-29
CA2828509A1 (en) 2012-09-07
TN2013000354A1 (en) 2015-01-20
EA201892052A1 (ru) 2019-02-28
IL228023A0 (en) 2013-09-30
US20130331579A1 (en) 2013-12-12
CN106083840B (zh) 2020-01-03
US9776966B2 (en) 2017-10-03
CN103402982A (zh) 2013-11-20
IL228023A (en) 2017-04-30
ES2663717T3 (es) 2018-04-16
HUE036319T2 (hu) 2018-06-28
NO2681192T3 (enExample) 2018-05-26
AU2012222346B2 (en) 2015-05-07

Similar Documents

Publication Publication Date Title
US9776966B2 (en) Synthesis of 2-carboxamide cycloamino urea derivatives
AU2016319638A1 (en) Tricyclic fused pyridin-2-one derivatives and their use as BRD4 inhibitors
JPH09227527A (ja) 4−オキソイミダゾリニウム塩の製造方法
JP6594351B2 (ja) 新規中間体を含むアルキル化アリールピペラジン及びアルキル化アリールピペリジン化合物の製造方法
HK1189578B (en) Synthesis of 2-carboxamide cycloamino urea derivatives
HK1189578A (en) Synthesis of 2-carboxamide cycloamino urea derivatives
NZ614173B2 (en) Synthesis of 2-carboxamide cycloamino urea derivatives
CN106892926B (zh) 一种dpp-iv抑制剂的中间体、其制备方法和通过其制备dpp-iv抑制剂的方法
WO2016023522A2 (en) Substituted phosphoramidate compounds and uses thereof
EA049707B1 (ru) Способ получения ингибитора cyp11a1 и соответствующих промежуточных соединений
US20060281756A1 (en) Synthesis of 3-amino-4-substituted pyrazole derivatives
HK1252869A1 (en) Method for removing dimethoxybenzyl
WO2015180593A1 (zh) 具有抗病毒活性的苯并杂环己二烯衍生物